Covered recipient · General Payments record
ANEETA J JOSEPH
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2019–2024
$1,400.53
- Reported across 64 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $385.34 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $150.99 | 4 |
| Corcept Therapeutics | $43.47 | 2 |
| SANOFI-AVENTIS U.S. LLC | $42.00 | 2 |
| Insulet Corporation | $35.65 | 2 |
| Lilly USA, LLC | $32.78 | 2 |
| Amgen Inc. | $30.60 | 2 |
| Medtronic, Inc. | $16.96 | 1 |
| Kyowa Kirin, Inc. | $16.49 | 1 |
| ABBVIE INC. | $16.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.76 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125042942 | CMS |
| Abbott Laboratories | $21.42 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125042944 | CMS |
| Abbott Laboratories | $17.06 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125042946 | CMS |
| Abbott Laboratories | $93.75 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125042948 | CMS |
| ABBVIE INC. | $16.40 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104011796 | CMS |
| Amgen Inc. | $15.28 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111611477 | CMS |
| Amgen Inc. | $15.32 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117290939 | CMS |
| Corcept Therapeutics | $18.88 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117768420 | CMS |
| Corcept Therapeutics | $24.59 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117768468 | CMS |
| Insulet Corporation | $16.50 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116795913 | CMS |
| Insulet Corporation | $19.15 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116800524 | CMS |
| Kyowa Kirin, Inc. | $16.49 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127025030 | CMS |
| Lilly USA, LLC | $14.82 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136036765 | CMS |
| Lilly USA, LLC | $17.96 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136040454 | CMS |
| Medtronic, Inc. | $16.96 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119299123 | CMS |
| SANOFI-AVENTIS U.S. LLC | $20.72 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139935839 | CMS |
| SANOFI-AVENTIS U.S. LLC | $21.28 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139935937 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.